Cardlytics (CDLX) to Release Quarterly Earnings on Wednesday

Cardlytics (NASDAQ:CDLX) is expected to be issuing its Q3 2025 results after the market closes on Wednesday, November 5th. Analysts expect the company to announce earnings of ($0.15) per share and revenue of $56.64 million for the quarter. Parties are encouraged to explore the company’s upcoming Q3 2025 earningoverview page for the latest details on the call scheduled for Wednesday, November 5, 2025 at 5:00 PM ET.

Cardlytics Stock Performance

Shares of CDLX stock opened at $1.99 on Wednesday. The business’s fifty day simple moving average is $1.74 and its 200-day simple moving average is $1.76. The company has a market cap of $105.95 million, a PE ratio of -0.55 and a beta of 1.45. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 2.87. Cardlytics has a 12-month low of $0.85 and a 12-month high of $5.24.

Insider Buying and Selling at Cardlytics

In other news, CEO Amit Gupta sold 68,685 shares of the business’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $1.12, for a total transaction of $76,927.20. Following the sale, the chief executive officer directly owned 491,759 shares of the company’s stock, valued at $550,770.08. The trade was a 12.26% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders have sold 159,335 shares of company stock worth $204,204 over the last 90 days. 4.40% of the stock is owned by insiders.

Institutional Investors Weigh In On Cardlytics

Several hedge funds and other institutional investors have recently added to or reduced their stakes in CDLX. Marshall Wace LLP purchased a new position in shares of Cardlytics during the 2nd quarter valued at about $59,000. XTX Topco Ltd boosted its stake in shares of Cardlytics by 143.5% in the second quarter. XTX Topco Ltd now owns 85,971 shares of the company’s stock worth $141,000 after buying an additional 50,663 shares during the last quarter. Finally, Jane Street Group LLC boosted its stake in shares of Cardlytics by 263.0% in the second quarter. Jane Street Group LLC now owns 162,427 shares of the company’s stock worth $267,000 after buying an additional 117,687 shares during the last quarter. 68.10% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

CDLX has been the topic of a number of recent analyst reports. Evercore ISI reduced their price target on Cardlytics from $3.00 to $2.00 and set an “in-line” rating on the stock in a research report on Friday, August 8th. Weiss Ratings reissued a “sell (e+)” rating on shares of Cardlytics in a report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $2.25.

About Cardlytics

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.